JPMORGAN CHASE & CO - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$20,000
+181718.2%
159,009
+43.6%
0.00%
Q4 2022$11
-99.9%
110,709
+1.8%
0.00%
Q3 2022$17,000
-81.5%
108,796
+4.4%
0.00%
Q2 2022$92,000
-18.6%
104,258
+14.4%
0.00%
Q1 2022$113,000
-23.1%
91,139
+21.4%
0.00%
Q4 2021$147,000
-72.6%
75,101
-61.6%
0.00%
Q3 2021$536,000
-18.3%
195,335
-6.2%
0.00%
Q2 2021$656,000208,2370.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders